← FDA Drug Approvals (Drugs@FDA)
RIZATRIPTAN BENZOATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PANACEA · Approved 2017-01-11
Drug application
- FDA Application #
ANDA204722- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIZATRIPTAN BENZOATE
- Generic name
- RIZATRIPTAN BENZOATE
- Active ingredients
- RIZATRIPTAN BENZOATE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PANACEA
- Manufacturer
- Panacea Biotec Limited
- First approval
- 2017-01-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown